TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis.
Gisondi P, Geat D, Conti A, Dapavo P, Piaserico S, De Simone C, Bianchi L, Costanzo A, Malagoli P, Malara G, Micali G, Naldi L, Offidani A, Patrizi A, Prignano F, Parodi A, Rongioletti F, Calzavara-Pinton P, Girolomoni G.
Gisondi P, et al. Among authors: naldi l.
Expert Rev Clin Immunol. 2020 Jun;16(6):591-598. doi: 10.1080/1744666X.2020.1771182. Epub 2020 Jun 4.
Expert Rev Clin Immunol. 2020.
PMID: 32419534
Review.